What plagues johnson jonson and proctor gamble companies

However, I think this one should go to JNJ. Also, if the level is already high, there may be more of a possibility that the dividend or the payout ratio could be reduced if business conditions for the company sour.

How you should view investment in each company today. At the end of the day, where your new money goes today should be more predicated on where things are going as opposed to where they have been.

A simple valuation comparison. Some investors look at a high payout ratio as a concern about whether a company What plagues johnson jonson and proctor gamble companies maintain that level.

In comparing the two to see which may outperform or provide a better dividend income stream, I have six financial and performance metrics that can be applied to identify some important areas that tip the scale towards the potentially better investment.

Want to share your opinion on this article? To report a factual error in this article, click here.

There's A World Of Difference Between Johnson & Johnson And Procter & Gamble

From that its book value suddenly rose greatly from the acquired equity of Gillette. Follow Adam Aloisi and get email alerts Your feedback matters to us! The general trend over the whole time period for both of them is tapering down.

The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. JNJ clearly had a lead in dividend growth from The author wrote this article themselves, and it expresses their own opinions.

Overall, PG wins this comparison. Do your own research and consult a professional, if necessary, before making investment decisions. So even though earnings barely grew, PG has raised its divvy by almost two thirds.

The author wrote this article themselves, and it expresses their own opinions. A number of the household items that each produce put them in roughly the same general retail space.

I would say PG won overall in this metric. Currently, PG pays the higher dividend- 2. It beat out JNJ until recently in I would say that this is pretty much a tie. The author has no business relationship with any company whose stock is mentioned in this article.

Huge market caps, perhaps indestructible business models, and a sleep-well-at-night reputation that appeals to the more conservative investor. The above should not be considered or construed as individualized or specific investment advice.

Conclusion I would opine based on all the above quantitative and qualitative data that an investor looking at both stocks should be buying JNJ here and probably not PG. The author is not receiving compensation for it other than from Seeking Alpha.

For many, these two are core holdings typically viewed as "forever" stocks. To report a factual error in this article, click here.

Investors are currently paying valuation premiums to own both of these stocks, although historically speaking, that is not uncommon. In this case, JNJ showed better overall performance in increasing book value per share.

Both values show that even after many years, they can achieve respectable earnings. They are market stalwarts that pay reliable returns to shareholders, and have probably been in the portfolios of many long-term investors. The author has no business relationship with any company whose stock is mentioned in this article.

For those who consider history important, JNJ seems to have much more appeal as a core holding for the dividend growth investor in my view.

Value, special situations, growth at reasonable price, long-term horizon Summary Two market stalwarts have been regular dividend payers.

Johnson & Johnson/ Procter & Gamble Comparison

Portfolio strategy, dividend investing, REITs, value Summary While many investors consider these two icons on an even standing, there are differences. The author is not receiving compensation for it other than from Seeking Alpha. JNJ are staple names for many of the products we buy.

Analysis of financial performance over the past decade and dividend payout ratios. In several years, the growth rate went negative for PG, showing a decrease in book value per share in those years.Better Buy: Johnson & Johnson vs.

Procter & Gamble Co Procter & Gamble and Johnson but you can explore which stock you're more comfortable with by looking at both companies from three.

Johnson & Johnson/ Procter & Gamble Comparison Add Remove Johnson & Johnson and Procter & Gamble these two companies are 2 that trade the similiar products and are in the same industry. Procter & Gamble Vs. Johnson & Johnson. Sep. 25, AM ET Long-term investors may prefer Johnson & Johnson over Procter & Gamble.

Both Procter in the two companies had. Procter & Gamble Sells Johnson Products Company, Leader in African-American Hair Care Products, to Newly Formed Independent Entity. Johnson & Johnson JNJ and Procter & Gamble PG are two companies with a massive array of products to offer consumers.

Johnson & Johnson has more of a health related focus across its product lines. There's A World Of Difference Between Johnson & Johnson And Procter & Gamble continue to gravitate to names like Johnson & Johnson (NYSE:JNJ) and Procter & Gamble with how these companies.

Bevor Sie fortfahren... Download
What plagues johnson jonson and proctor gamble companies
Rated 4/5 based on 79 review